Eich, Marcus <br/><br/>
Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide.  [electronic resource] 

 -  Molecular pharmacology  Nov 2010 
 - 943-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0111 
<br/><br/><label>Standard No.: </label>10.1124/mol.110.066076  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Apoptosis<br/>Caspase 7--metabolism<br/>Cell Cycle Proteins--genetics<br/>Cell Line, Transformed<br/>Cell Line, Tumor<br/>DNA Methylation<br/>Dacarbazine--analogs & derivatives<br/>Drug Resistance, Neoplasm<br/>Fibroblasts--drug effects<br/>Guanine--analogs & derivatives<br/>Homozygote<br/>Humans<br/>Melanoma<br/>Methylnitronitrosoguanidine--pharmacology<br/>Mutagens--pharmacology<br/>Mutation<br/>Necrosis<br/>Nijmegen Breakage Syndrome--pathology<br/>Nuclear Proteins--genetics<br/>Poly (ADP-Ribose) Polymerase-1<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Temozolomide<br/>Uveal Neoplasms<br/>Uveal Melanoma